Rheumatic Disease Clinics of North America

Papers
(The median citation count of Rheumatic Disease Clinics of North America is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Copyright115
Contents104
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases64
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network45
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis34
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis33
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis27
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children25
Osteoarthritis Treatment Guidelines from Six Professional Societies21
Copyright18
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy17
Forthcoming Issues15
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica15
COPA Syndrome from Diagnosis to Treatment14
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota14
Lessons Learned from the COVID-19 Pandemic in Rheumatology13
Taxonomy of Quality of Care Indicators13
The Short and Long of COVID-1913
Contributors13
Imaging Challenges and Developments in Large-vessel Vasculitis12
Venous Thromboembolism in the Inflammatory Rheumatic Diseases12
Copyright12
De novo Connective Tissue Disorders as Immune-related Adverse Events11
Contributors11
Pulmonary Hypertension Associated with Connective Tissue Disease11
Contents10
It Takes Oysters to Generate Pearls9
Copyright9
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease9
Vaccinations in Patients with Rheumatic Disease9
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events8
Daniel J McCarty, MD: A Giant of Rheumatology8
COVID-19 and Rheumatology8
Primary Cardiac Involvement in Systemic Sclerosis8
Expanding the Treatment Team8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis8
Newer Immunosuppressants for Rheumatologic Disease8
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease8
Charles L Christian8
Rheumatology Pearls for the Primary Care Physician7
Preventative Care in Scleroderma7
Scleroderma: Best Approaches to Patient Care7
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 20197
Cardiac MRI in Rheumatic Disease6
Copyright6
The Challenges of New Biologic Therapies in Pediatrics6
Imaging of the Major Salivary Glands in Rheumatic Disease6
Contents6
Imaging of Pulmonary Manifestations of Connective Tissue Disease6
Sustainable Health Care and Advocacy for Rheumatologists6
A Guide to Contemporary Clinical Practice Guidelines6
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies6
E Carwile LeRoy, MD6
Contributors6
Guideline Development and Implementation in Rheumatic Disease6
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus6
Heart Failure in Rheumatic Disease5
Forthcoming Issues5
Myositis5
Contents5
Copyright5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis5
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD5
Beyond Coronary Artery Disease5
Impacts of Storms, Precipitation, Drought, and Water Quality on Rheumatic Diseases5
Contributors5
SARS-CoV-2 Infection and COVID-19 in Children4
Treatment Guidelines in Gout4
Treatment Guidelines in Pediatric Rheumatic Diseases4
Genetic Defects in Early-Onset Inflammatory Bowel Disease4
Emerging and Expanding Infections due to Climate Change of Concern to Rheumatologists4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases4
Management and Cure of Gouty Arthritis4
Dual-Energy Computed Tomography Applications in Rheumatology4
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”4
Copyright4
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis3
Achieving Precision Medicine in Psoriatic Arthritis3
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk3
Forthcoming Issues3
Interstitial Lung Disease3
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury3
Health Care Utilization3
Expanding IPEX: Inborn Errors of Regulatory T Cells3
Contents3
The Effects of Extreme Heat on Individuals with Rheumatic Conditions3
Imaging in Inflammatory Bowel Disease3
The Role of Psychology in Pediatric Rheumatic Diseases3
Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus3
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica3
Impact of Climate Change on Rheumatology Care3
Myositis in 2025: Defining Subtypes, Closing Gaps, and Shaping the Future2
The GRADE Method2
Rheumatology Care in an Aging World2
Forthcoming Issues2
Forthcoming Issues2
Training the Next Generation of Rheumatologists2
Forthcoming Issues2
Forthcoming Issues2
Patient-Reported Outcomes in Myositis2
Imaging in Juvenile Idiopathic Arthritis2
Emerging Treatment Options for Inclusion Body Myositis2
Diagnostic Evaluation for Myositis and Their Pitfalls2
Perioperative Management of Rheumatic Disease and Therapies2
Axial Imaging in Spondyloarthritis1
Hal Holman of Stanford1
The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis1
Rheumatic Complications of Immune Checkpoint Inhibitors1
Foreword1
Long COVID for the Rheumatologist1
Impact of Stress and Eco-anxiety on Rheumatic Disease1
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis1
Imaging in Rheumatology1
Highlights of Interdisciplinary Care in Rheumatology1
Gerald P Rodnan1
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis1
Climate Change, Pollution, and Sustainability1
Pesticides, Rheumatic Diseases, and Emerging Environmental Threats1
The Current and Future of Biomarkers of Immune Related Adverse Events1
Novel Therapeutic Targets in the Management of Psoriatic Disease1
Classification Criteria in Idiopathic Inflammatory Myopathies: Is It Time for an Update?1
Forthcoming Issues1
Foreword1
Treatment of Vascular Complications in Systemic Sclerosis1
Treatment of Inflammatory Arthritis in Systemic Sclerosis1
Cardiovascular Disease in Large Vessel Vasculitis1
Targeted Treatment of Diseases of Immune Dysregulation1
J. Claude Bennett, MD1
Foreword1
Nathan Zvaifler1
Targeting Environmental Risks to Prevent Rheumatic Disease1
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis1
Contributors1
Promising Treatments in Juvenile Dermatomyositis1
Immune Checkpoint Inhibitor-induced Myositis1
Foreword1
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy1
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis1
Treatment Guidelines in Vasculitis1
The Mythology of Polymyositis1
Vasculitis1
Forthcoming Issues1
Preface1
Systemic Diseases and Heart Block1
Contributors1
The Giants Of Rheumatology1
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination0
Climate Change and the Exposome in Autoimmune Rheumatic Diseases0
Food as Medicine for Rheumatic Diseases and Planetary Health0
The Future of Vasculitis0
Environmental Triggers for Vasculitis0
Managing Cardiovascular Risk in Patients with Rheumatic Disease0
Integrative Rheumatology0
Mental Health Considerations in Chronic Disease0
Scleroderma: Best Approaches to Patient Care0
Environmental Risks for Inflammatory Myopathies0
Contents0
Contents0
Rheumatic Immune-related Adverse Events0
Physical Activity for Human and Planetary Health0
Isolated Aortitis0
Persistent Gaps in Global Rheumatology Research and Care0
Rheumatology Pearls for the Primary Care Physician0
Environmental Risks for Systemic Sclerosis0
Vasculitis Mimics and Other Related Conditions0
Environmental Triggers for Rheumatic Diseases0
Contributors0
Contents0
Lessons from Carl M. Pearson 1919 – 19810
Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome0
Imaging of Rheumatic Diseases Affecting the Lower Limb0
Eric Bywaters and Barbara Ansell0
How the American College of Rheumatology Develops Guidelines0
Vasculitis0
Imaging Revolutions in Modern Rheumatology0
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases0
Contributors0
Management of Knee Osteoarthritis0
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders0
Rheumatoid Arthritis0
Imaging in Rheumatology0
Copyright0
Psoriatic Arthritis Updates0
Epidemiologic Opportunities and Challenges in Studying Environmental Risk Factors for Rheumatic Diseases0
Emerging Concepts in Immune Dysregulation0
Challenges in Developing Treatment Guidelines in Psoriatic Arthritis0
Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis0
Suppressor of Cytokine Signaling 1 Haploinsufficiency0
Forthcoming Issues0
Copyright0
The Future of Rheumatology Leadership in Africa0
Contents0
The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases0
New Developments in Imaging in Crystalline Arthritis0
Contributors0
Management of Lung Manifestations in Idiopathic Inflammatory Myopathies0
Systemic Lupus Erythematosus Risk0
Emerging Concepts in Immune Dysregulation0
Copyright0
Environmental Triggers for Rheumatic Diseases0
Cardiovascular Complications of Chronic Rheumatic Diseases0
Scleroderma Skin0
Newer Immunosuppressants for Rheumatologic Disease0
Calcinosis in Adult and Juvenile Dermatomyositis0
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients0
Prospects of Disease-Modifying Osteoarthritis Drugs0
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases0
Contents0
Contributors0
Emerging Concepts in the Diagnosis and Treatment of Systemic Vasculitis0
Forthcoming Issues0
The Burden of Post-Acute Sequelae of Coronavirus Disease 2019 in Individuals with Rheumatic Diseases0
Axial Psoriatic Arthritis0
It Takes a Village0
Type I Interferonopathies0
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination0
Forthcoming Issues0
Gastrointestinal Tract Considerations: Part II0
Overview of Climate Change, Pollution, and Sustainability in the Rheumatic and Autoimmune Diseases0
Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis0
Environmental Risks for Spondyloarthropathies0
Patient Experience of Systemic Sclerosis–Related Calcinosis0
Lessons on Telemedicine in Rheumatology0
Contributors0
New and Emerging Rheumatic Diseases0
Naomi Rothfield, MD, MACR0
Foreword0
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease0
Interventions to Improve COVID-19 Vaccine Hesitancy0
Foreword0
Forthcoming Issues0
Updates in the Management of Immune-Mediated Necrotizing Myopathy0
Guideline Development and Implementation in Rheumatic Disease0
Forthcoming Issues0
Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases:0
Copyright0
Rheumatology Care Among Indigenous Populations0
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology0
Immunotherapy Toxicity Management in Clinical Practice0
Central Nervous System Vasculitis0
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis0
Lung Microbiome in Autoimmune-Associated Interstitial Lung Disease0
Giant Cell Arteritis and Polymyalgia Rheumatica0
Best Approaches to the Care of Systemic Sclerosis Patients0
Rheumatic Immune-Related Adverse Events: Current Clinical Imperatives Underpin Future Novel Insights0
Preventative Care in Scleroderma0
Vasculitis and Pregnancy0
NF-κB and Related Autoimmune and Autoinflammatory Diseases0
0.14035987854004